Search clinical trials for: AVP-786 Dose 1
Total 1482 results
-
Avanir PharmaceuticalsCompleted
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Participants With Dementia of the Alzheimer's TypeUnited States, Canada
-
Boehringer IngelheimCompleted
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompleted
-
Ariston Pharmaceuticals, Inc.UnknownMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraFinland, Netherlands, United Kingdom
-
Avanir PharmaceuticalsCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedIntermittent Explosive DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Belgium, Canada, Chile, Colombia, Croatia, Hungary, Mexico, Netherlands, Slovakia, Slovenia, Spain, Ireland
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Bulgaria, Denmark, Estonia, Greece, Poland, Portugal, Puerto Rico, United Kingdom, Germany, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeSpain, United States, Italy, United Kingdom, Hungary, France, Poland, Australia, Bulgaria, Czechia, South Africa
-
Boehringer IngelheimCompleted
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedSchizophreniaUnited States, Bulgaria, Poland, Puerto Rico
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
Rutgers, The State University of New JerseyCenters for Disease Control and PreventionCompletedViolence | Helping Behavior | Sexual Assault and Rape | Assaultive BehaviorUnited States
-
University of MinnesotaRecruitingSolid Organ TransplantUnited States
-
Basilea PharmaceuticaCompletedFungal InfectionNetherlands
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Avanir PharmaceuticalsCompletedSchizophreniaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Estonia, Germany, Poland, Portugal, Puerto Rico
-
PATHCompleted
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Russian Federation, Germany, Canada, Belgium, United Kingdom
-
Shanghai Municipal Center for Disease Control and...Shanghai Institute Of Biological ProductsUnknown
-
IntegoGen, LLCWithdrawnHidradenitis SuppurativaUnited States
-
Zensun Sci. & Tech. Co., Ltd.Zensun USA Inc.CompletedChronic Heart FailureUnited States
-
Boehringer IngelheimCompleted
-
ACADIA Pharmaceuticals Inc.CompletedAcute Postoperative Pain | BunionectomyUnited States
-
ACADIA Pharmaceuticals Inc.TerminatedOsteoarthritis PainUnited States
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707 | Pharmacodynamics of ASP1707France
-
Virginia Commonwealth UniversityGilead SciencesWithdrawnChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | Refractory Small Lymphocytic Lymphoma | SLL | Relapsed CLL | Relapsed Chronic Lymphocytic Leukemia | Relapsed Small Lymphocytic Lymphoma
-
Oryn Therapeutics, LLCCompletedRheumatoid ArthritisUnited States
-
Boehringer IngelheimCompleted
-
Loyola UniversityNational Cancer Institute (NCI)Active, not recruiting
-
Chong Kun Dang PharmaceuticalUnknown
-
Renibus Therapeutics, Inc.CompletedAKIUnited States, Australia, Canada
-
Aronora, Inc.CompletedThrombosis | End Stage Renal DiseaseUnited States
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAgitation in Patients With Dementia of the Alzheimer's TypeUnited States, Spain, Hungary, Italy, Canada, Czechia, South Africa, Bulgaria, France, Poland
-
Pharnext SACompletedPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)Charcot-Marie-Tooth Disease Type 1AUnited States, United Kingdom, Belgium, Canada, France, Netherlands, Spain, Germany
-
Ehab L AtallahRecruitingAcute Myeloid Leukemia | T Cell Lymphoblastic Lymphoma | T Cell Acute Lymphoblastic LeukemiaUnited States
-
University of EdinburghUmeå UniversityCompletedCoronary DiseaseSweden
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis InfectionUnited States
-
University of Sao Paulo General HospitalCompleted
-
Centre Hospitalier Universitaire de Saint EtienneSanofi Pasteur, a Sanofi Company; Bioster, a.s.Completed
-
Galapagos NVCompletedCystic FibrosisBelgium, Netherlands
-
NVP HealthcareWithdrawn
-
Oryn Therapeutics, LLCWithdrawn